tiprankstipranks
Trending News
More News >
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
US Market
Advertisement

ImmunoPrecise Antibodies (IPA) Income Statement

Compare
354 Followers

ImmunoPrecise Antibodies Income Statement

Last quarter (Q3 2025), ImmunoPrecise Antibodies's total revenue was C$6.15M, a decrease of -1.13% from the same quarter last year. In Q3, ImmunoPrecise Antibodies's net income was C$-21.52M. See ImmunoPrecise Antibodies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 24.52MC$ 24.52MC$ 20.66MC$ 19.36MC$ 17.91M
Gross Profit
C$ 13.55MC$ 12.05MC$ 11.56MC$ 10.98MC$ 11.54M
Operating Expenses
C$ 25.74MC$ 25.82MC$ 37.17MC$ 27.66MC$ 15.71M
Depreciation and Amortization
C$ 5.12MC$ 5.74MC$ 6.68MC$ 3.77MC$ 3.71M
EBITDA
C$ -28.86MC$ -22.95MC$ -21.04MC$ -11.99MC$ -1.42M
Operating Income
C$ -12.20MC$ -13.76MC$ -25.61MC$ -15.78MC$ -4.18M
Other Income/Expenses
C$ -22.07MC$ -14.94MC$ -2.14MC$ -67.00KC$ -1.82M
Pretax Income
C$ -34.27MC$ -28.70MC$ -27.75MC$ -15.85MC$ -6.00M
Net Income
C$ -30.23MC$ -27.18MC$ -26.56MC$ -16.71MC$ -7.34M
Per Share Metrics
Basic EPS
C$ -0.91C$ -1.06C$ -1.07C$ -0.85C$ -0.45
Diluted EPS
C$ -0.91C$ -1.06C$ -1.07C$ -0.85C$ -0.45
Weighted Average Shares Outstanding
33.38M 25.64M 24.90M 19.69M 16.47M
Weighted Average Shares Outstanding (Diluted)
33.38M 25.64M 24.90M 19.69M 16.47M
Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis